JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,135,000 | +37.6% | 67,600 | -31.9% | 0.05% | +43.8% |
| Q3 2017 | $825,000 | +59.9% | 99,300 | -17.7% | 0.03% | +68.4% |
| Q2 2017 | $516,000 | +5.7% | 120,700 | +5.5% | 0.02% | -5.0% |
| Q1 2017 | $488,000 | -38.5% | 114,358 | -31.5% | 0.02% | -31.0% |
| Q4 2016 | $793,000 | +10.1% | 167,058 | -6.9% | 0.03% | -9.4% |
| Q3 2016 | $720,000 | -52.9% | 179,362 | +36.4% | 0.03% | -58.4% |
| Q2 2016 | $1,528,000 | +34.3% | 131,458 | +41.0% | 0.08% | +2.7% |
| Q1 2016 | $1,138,000 | +31.1% | 93,239 | +10.3% | 0.08% | +56.2% |
| Q4 2015 | $868,000 | – | 84,500 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 1,864,174 | $83,627,000 | 94.97% |
| Crestline Management, LP | 9,348,799 | $419,387,000 | 58.30% |
| Omega Fund Management, LLC | 1,074,612 | $48,207,000 | 27.27% |
| PECONIC PARTNERS LLC | 570,000 | $25,570,000 | 4.12% |
| SIB LLC | 100,000 | $4,486,000 | 3.22% |
| Cormorant Asset Management, LP | 375,000 | $16,823,000 | 2.97% |
| BB BIOTECH AG | 2,055,000 | $92,187,000 | 2.55% |
| Clarius Group, LLC | 117,896 | $5,289,000 | 2.23% |
| Monashee Investment Management LLC | 122,000 | $5,473,000 | 2.07% |
| Iguana Healthcare Management, LLC | 150,000 | $6,730,000 | 1.86% |